Literature DB >> 15521244

Cerebral venous sinus thrombosis in Behcet's disease: a case report.

Chusak Limotai1, Kammant Phanthumchinda.   

Abstract

Behcet's disease ( BD ) is a systemic inflammatory vascular disease with variable clinical manifestations and numerous clinical masquerades. The venous involvement may affect veins of different size with tendency for thrombosis. BD is the commonest cause of cerebral venous thrombosis in some Middle Eastern countries. However, in Thailand, this clinical entity has been rarely described as a cause of cerebral venous sinus thrombosis. A 38 year-old man presented with recurrent attacks of transient ischemic attack (TIA) for 9 months. Two months after the TIA, he developed right hemiparesis and persistent diffuse headache. He had a 10 year history of recurrent oral and genital ulcers. Physical examination revealed bilateral uveitis, right hemiparesis, bilateral sixth cranial nerve paresis and bilateral papilloedema. Pathergy skin test showed positive result. Neuroimaging demonstrated empty delta sign on CT-scan and thrombosis of the posterior part of superior saggital sinus, transverse sinus, straight sinus and internal jugular vein on magnetic resonance venography (MRV). Cerebrospinal fluid (CSF) analysis revealed increased intracranial pressure and aseptic CSF profiles. Prednisolone, chlorambucil and anticoagulant had been prescribed. The clinical course improved gradually.

Entities:  

Mesh:

Year:  2004        PMID: 15521244

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Transient hemiparesis due to a ruptured cerebral aneurysm in the prehospital setting.

Authors:  Youichi Yanagawa; Kazuoki Hirano; Arisa Hayashida; Tomoko Nakazato
Journal:  BMJ Case Rep       Date:  2013-08-02

2.  Cerebral Venous Thrombosis in Behçet's Disease Patients Compared to Other Causes of Cerebral Venous Thrombosis: a Retrospective Study.

Authors:  Mine Hayriye Sorgun; Sefer Rzayev; Mustafa Aykut Kural; Seyda Erdoğan; Canan Yücesan
Journal:  Arch Rheumatol       Date:  2016-05-17       Impact factor: 1.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.